DP
DalCor Pharmaceuticals US, LLC
SEC filingPharmaceuticals · Sarasota, FL
Amount raised$7Msold at filing
Total offering$7M
Investors in the raise8count reported to the SEC
FiledAug 28, 2026first sale Jul 30, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Douglas Michael DixonDirector
Paul Michael FonteyneDirector
Executive officers, directors and promoters as listed on the Form D.